During the past decade, Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi" #1 sponsor was "Pfizer" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi" are "Cardiovascular Disease" (2 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi" in a lesser frequency.

Most popular intervention types in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi" are "Drug" (10 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Pembrolizumab" (3 trials), "Carboplatin" (2 trials), "Olaparib" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".